Inventor · disambiguated record
James Thomas Anderson
Also filed as: ANDERSON JAMES T · ANDERSON JAMES THOMAS
5 granted patents·4 pending applications·12 citations·filing 2003–2015
71Inventor score
Top patents by PatentIndex Score
9 records- 0179US10328082B2Methods of use and combinationsPFIZER·Filed 2015·Granted Jun 25, 2019·4 cites·6 claims
- 0275US9328104B2Selective androgen receptor modulatorsPFIZER·Filed 2013·Granted May 3, 2016·4 cites·13 claims
- 0367US6787664B2Process for preparing single enantiomers of 5,5,5,5′,5′,5′-hexafluoroleucine and protected analogsWARNER LAMBERT CO·Filed 2003·Granted Sep 7, 2004·4 cites·14 claims
- 0453US2010015141A14-phenoxy-6-aryl-1h-pyrazolo[3,4-d]pyrimidine and n-aryl-6-aryl-1h-pyrazolo[3,4-d]pyrimidin-4-amine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their synthesesWYETH CORP·Filed 2009·Application pending·0 cites
- 0552US2009192147A1[a]-FUSED INDOLE COMPOUNDS, THEIR USE AS mTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESESWYETH CORP·Filed 2009·Application pending·0 cites
- 0648US2009311217A13-substituted-1h-indole compounds, their use as mtor kinase and pi3 kinase inhibitors, and their synthesesWYETH CORP·Filed 2009·Application pending·0 cites
- 0747US6974879B2Process for preparing single enantiomers of 5,5,5,5′,5′,5′-hexafluoroleucine and protected analogsWARNER LAMBERT CO·Filed 2004·Granted Dec 13, 2005·0 cites·6 claims
- 0843US7319103B2Non-imidazole tertiary amines as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other CNS disordersATHERSYS INC·Filed 2005·Granted Jan 15, 2008·0 cites·5 claims
- 0939US2005049278A1Benzo[1,3]dioxole compounds, pharmaceutical compositions thereof, and processes of making and using the sameFiled 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when James Thomas Anderson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →